Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 34.8B | 34.6B | 39.3B | 35.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 5.3B | 6.3B | 5.1B | 4.9B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 5.2B | 3.1B | 6.5B | 12.5B |
| Tax provision | 1.5B | -67.2M | 2.2B | 3.1B |
| Net income | 3.7B | 3.2B | 4.3B | 9.4B |
| Basic EPS | 2.3 | — | 2.7 | 5.8 |
| Diluted EPS | 2.3 | — | 2.7 | 5.8 |
| Basic average shares | 1.6B | — | 1.6B | 1.6B |
| Diluted average shares | 1.6B | — | 1.6B | 1.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |